United Bank (West Virginia)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$5.25M Buy
28,160
+279
+1% +$49.4K 2.09% 15
2017
Q2
$4.8M Buy
27,881
+1,404
+5% +$228K 2.02% 15
2017
Q1
$4.34M Buy
26,477
+2,867
+12% +$476K 1.89% 14
2016
Q4
$3.45M Buy
23,610
+11,608
+97% +$1.75M 1.53% 20
2016
Q3
$2M Buy
12,002
+6,346
+112% +$1.07M 0.92% 30
2016
Q2
$861K Buy
5,656
+1,227
+28% +$191K 0.4% 45
2016
Q1
$664K Buy
4,429
+800
+22% +$119K 0.3% 49
2015
Q4
$589K Buy
3,629
+850
+31% +$134K 0.28% 47
2015
Q3
$384K Sell
2,779
-1,338
-32% -$211K 0.2% 58
2015
Q2
$632K Buy
+4,117
New +$660K 0.28% 44

Other funds holding AMGN

United Bank (West Virginia)'s AMGN Position: Q3 2017 in Review

United Bank (West Virginia) increased its Amgen (AMGN) stake by 1% in Q3 2017, buying an estimated $49.4K and bringing the position to 28,160 shares worth $5.25M. The position accounts for 2.09% of the portfolio, ranked #15.

United Bank (West Virginia) first reported a position in AMGN in Q2 2015 and has held it in 10 quarters since. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • United Bank (West Virginia) held 28,160 shares of Amgen worth $5.25M as of Q3 2017.
  • United Bank (West Virginia) bought 279 Amgen shares in Q3 2017, an estimated $49.4K.
  • Amgen made up 2.09% of United Bank (West Virginia)'s portfolio in Q3 2017, its #15 holding.
  • United Bank (West Virginia) first reported a position in Amgen in Q2 2015 and has held it in 10 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on United Bank (West Virginia)'s 13F filing for Q3 2017, filed 26 Oct 2017.